Abstract
Background
Parathyroid carcinoma (PC) is a rare malignancy that is difficult to eradicate completely after recurrence. We assessed the efficiency of extended en bloc resection (EEBR) in the management of recurrent or persistent PC.
Methods
In this observational cohort study, 31 patients who underwent reoperations for recurrent or persistent PC were enrolled after 2–9 surgeries by other medical teams. EEBRs, which provided the oncologic resection by removing all possible tumor-bearing scar tissues, were adopted in 25 patients. The other 6 with gross infiltration into the upper aerodigestive tract (UAT) underwent less radical procedures for unwillingness to sacrifice laryngeal function.
Results
The 5-year overall survival (OS) rate after EEBR was 59.6% compared with 16.7% after less radical procedures, with an improved median expected survival time of 90.0 months compared with 13.0 months after local excision. EEBR exhibited a favorable local control of relapses in 84.0% of patients after a median follow-up period of 27.0 months, 40.0% even achieved disease-free survival, although 56.0% had subsequent distant metastases (DMs) and suffered a worse 5-year OS of 36.7% in contrast with 100.0% in the absence of DM (p = 0.011). UAT invasion, rather than age, number of previous operations, or preoperative PTH levels, was the unique independent factor associated with both DM (HR = 5.466, p = 0.006) and mortality (HR = 7.606, p = 0.011).
Conclusion
EEBRs provide better outcomes than other conventional surgical approaches and might offer a second chance of cure for patients with recurrent or persistent PC in the absence of DM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Xue S, Chen H, Lv C, et al. Preoperative Diagnosis and Prognosis in 40 Parathyroid Carcinoma Patients. Clin Endocrinol (Oxf). 2016;85(1):29-36.
Harari A, Waring A, Fernandez-Ranvier G, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679-3686.
Talat N, Schulte KM. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol. 2010;17(8):2156-2174.
Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959-968.
Wang P, Xue S, Wang S, et al. Clinical characteristics and treatment outcomes of parathyroid carcinoma: a retrospective review of 234 cases. Oncol Lett. 2017;14(6):7276-7282.
Ryhänen EM, Leijon H, Metso S, et al. A nationwide study on parathyroid carcinoma. Acta Oncol. 2017;56(7):991-1003.
Hu Y, Bi Y, Cui M, et al. The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute. Endocr Pract. 2019;25(7):634-641.
Silva-Figueroa AM, Hess KR, Williams MD, et al. Prognostic scoring system to risk stratify parathyroid carcinoma. J Am Coll Surg. 2017;S1072-7515(17)30179-5.
Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11-23.
Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136(8):878-885.
Silverberg SJ, Rubin MR, Faiman C, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab. 2007;92(10):3803-3808.
Asare EA, Silva-Figueroa A, Hess KR, et al. Risk of distant metastasis in parathyroid carcinoma and its effect on survival: a retrospective review from a high-volume center. Ann Surg Oncol. 2019;26(11):3593-3599.
Schulte KM, Talat N. Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol. 2012;8(10):612-622.
Asare EA, Sturgeon C, Winchester DJ, et al. Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB). Ann Surg Oncol. 2015;22(12):3990-3995.
Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16(4):724-731.
Hsu KT, Sippel RS, Chen H, Schneider DF. Is central lymph node dissection necessary for parathyroid carcinoma? Surgery. 2014;156(6):1336-1341; discussion 1341.
Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S. Lymph node involvement and surgical approach in parathyroid cancer. World J Surg. 2010;34(11):2611-2620.
Pradhan R, Mayilvaganan S, Agarwal A. Parathyroid carcinoma: current concepts. In: Parameswaran R, Agarwal A, eds. Evidence-based endocrine surgery. Singapore: Springer, 2018:307-317.
Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485-493.
Acknowledgements
This study was supported by the Science and Technology Project of Chaoyang District (CYSF2053). We gratefully acknowledge the assistance of Prof. Guiyi Tu for invaluable technical guidance.
Funding
This study was supported by the Science and Technology Project of Chaoyang District (CYSF2053)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors report no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wei, B., Zhao, T., Shen, H. et al. Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience. Ann Surg Oncol 29, 1208–1215 (2022). https://doi.org/10.1245/s10434-021-10962-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10962-7